Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
Vari, Frank, Arpon, David, Keane, Colm, Hertzberg, Mark S., Talaulikar, Dipti, Jain, Sanjiv, Cui, Qingyan, Han, Erica, Tobin, Josh, Bird, Robert, Cross, Donna, Hernandez, Annette, Gould, Clare, Birch, Simone, Gandhi, Maher K.
Published in Blood (19.04.2018)
Published in Blood (19.04.2018)
Get full text
Journal Article
KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
Swords, Ronan T., MD, PhD, FRCPI, FRCPath, Greenberg, Peter L., MD, Wei, Andrew H., MBBS, PhD, Durrant, Simon, MBBS, MRCS, LRCP, FRCP, FRCPath, Advani, Anjali S., MD, Hertzberg, Mark S., MBBS, PhD, FRACP, FRCPA, Lewis, Ian D., MBBS, PhD, Rivera, Gabriel, MD, Gratzinger, Dita, MD, PhD, Fan, Alice C., MD, Felsher, Dean W., MD, PhD, Cortes, Jorge E., MD, Watts, Justin M., MD, Yarranton, Geoff T., PhD, Walling, Jackie M., MB, ChB, PhD, Lancet, Jeffrey E., MD
Published in Leukemia research (01.11.2016)
Published in Leukemia research (01.11.2016)
Get full text
Journal Article
Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729]
Swords, Ronan T., MD, PhD, Greenberg, Peter L., MD, Wei, Andrew H., MBBS, PhD, Durrant, Simon, MBBS, Advani, Anjali S., MD, Hertzberg, Mark S., MBBS, PhD, Lewis, Ian D., MBBS, PhD, Rivera, Gabriel, MD, Gratzinger, Dita, MD, PhD, Fan, Alice C., MD, Felsher, Dean W., MD, PhD, Cortes, Jorge E., MD, Watts, Justin M., MD, Yarranton, Geoff T., PhD, Walling, Jackie M., MB, ChB, PhD, Lancet, Jeffrey E., MD
Published in Leukemia research (01.08.2017)
Published in Leukemia research (01.08.2017)
Get full text
Journal Article
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia
He, Simon Z., Busfield, Samantha, Ritchie, David S., Hertzberg, Mark S., Durrant, Simon, Lewis, Ian D., Marlton, Paula, McLachlan, Andrew J., Kerridge, Ian, Bradstock, Kenneth F., Kennedy, Glen, Boyd, Andrew W., Yeadon, Trina M., Lopez, Angel F., Ramshaw, Hayley S., Iland, Harry, Bamford, Simone, Barnden, Megan, DeWitte, Mark, Basser, Russell, Roberts, Andrew W.
Published in Leukemia & lymphoma (01.05.2015)
Published in Leukemia & lymphoma (01.05.2015)
Get full text
Journal Article
Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
Cui, Qingyan, Vari, Frank, Cristino, Alexandre S, Salomon, Carlos, Rice, Gregory E, Sabdia, Muhammed B, Guanzon, Dominic, Palma, Carlos, Mathew, Marina, Talaulikar, Dipti, Jain, Sanjiv, Han, Erica, Hertzberg, Mark S, Gould, Clare, Crooks, Pauline, Thillaiyampalam, Gayathri, Keane, Colm, Gandhi, Maher K
Published in Oncotarget (05.10.2018)
Published in Oncotarget (05.10.2018)
Get full text
Journal Article
Nephrotic syndrome after stem cell transplantation
Stevenson, William S, Nankivell, Brian J, Hertzberg, Mark S
Published in Clinical transplantation (01.02.2005)
Published in Clinical transplantation (01.02.2005)
Get full text
Journal Article
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors
Klyuchnikov, Evgeny, Bacher, Ulrike, Kröger, Nicolaus M, Hari, Parameswaran N, Ahn, Kwang Woo, Carreras, Jeanette, Bachanova, Veronika, Bashey, Asad, Cohen, Jonathon B, D'Souza, Anita, Freytes, César O, Gale, Robert Peter, Ganguly, Siddhartha, Hertzberg, Mark S, Holmberg, Leona A, Kharfan-Dabaja, Mohamed A, Klein, Andreas, Ku, Grace H, Laport, Ginna G, Lazarus, Hillard M, Miller, Alan M, Mussetti, Alberto, Olsson, Richard F, Slavin, Shimon, Usmani, Saad Z, Vij, Ravi, Wood, William A, Maloney, David G, Sureda, Anna M, Smith, Sonali M, Hamadani, Mehdi
Published in Biology of blood and marrow transplantation (01.12.2015)
Published in Biology of blood and marrow transplantation (01.12.2015)
Get full text
Journal Article
Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone
Hertzberg, Mark S., Favaloro, Emmanuel, Koutts, Jerry
Published in American journal of hematology (01.08.2002)
Published in American journal of hematology (01.08.2002)
Get full text
Journal Article
Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial
Ferdinandus, Justin, Schneider, Gundolf, Fosså, Alexander, Moccia, Alden, Greil, Richard, Hertzberg, Mark S., Zijlstra, Josée M., Kamper, Peter, Molin, Daniel L., Kerkhoff, Andrea, Scholl, Sebastian, Ko, Yon-Dschun, Topp, Max S., Beck, Joachim, Vucinic, Vladan, Jung, Wolfram, Schroers, Roland, Rank, Andreas, Damaschin, Carla, Jacob, Anne Sophie, Fuchs, Michael, Borchmann, Peter, Behringer, Karolin
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Comprehensive Analysis of Treatment Related Morbidity and Progression -Free Survival in the GHSG Phase III HD21 Trial
Borchmann, Peter, Moccia, Alden, Greil, Richard, Schneider, Gundolf, Hertzberg, Mark S., Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Schaub, Valdete, Hänel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josée M, Fosså, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel L., Kreissl, Stefanie, Ferdinandus, Justin, Fuchs, Michael, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL
Macaulay, Charles, Alig, Stefan, Kurtz, David M., Jin, Michael C., Opat, Stephen, Soo, Joanne, Sworder, Brian, Hertzberg, Mark S., Gandhi, Maher K., Diehn, Maximilian, Alizadeh, Ash A.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL
Gould, Clare, Keane, Colm, Murigneux, Valentine, Oey, Harald, Ellis, Jonathan, Birch, Simone, Gunawardana, Jay, Talaulikar, Dipti, Hertzberg, Mark S., Jones, Kimberley, Gandhi, Maher K.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
Dimopoulos, Meletios A, Richardson, Paul G, Bahlis, Nizar J, Grosicki, Sebastian, Cavo, Michele, Beksaç, Meral, Legieć, Wojciech, Liberati, Anna M, Goldschmidt, Hartmut, Belch, Andrew, Magen, Hila, Larocca, Alessandra, Laubach, Jacob P, Petrucci, Maria T, Reece, Donna, White, Darrell, Mateos, María-Victoria, Špička, Ivan, Lazaroiu, Mihaela, Berdeja, Jesús, Kaufman, Jonathan L, Jou, Ying-Ming, Ganetsky, Alex, Popa McKiver, Mihaela, Lonial, Sagar, Weisel, Katja
Published in The Lancet. Haematology (01.06.2022)
Published in The Lancet. Haematology (01.06.2022)
Get more information
Journal Article
Type 2B von Willebrand's disease and angiodysplasia
Hertzberg, M S, Facey, D A, Favaloro, E J, Koutts, J
Published in Thrombosis and haemostasis (01.11.1999)
Published in Thrombosis and haemostasis (01.11.1999)
Get more information
Journal Article
A Novel Anti-Lymphoma Immune Evasion Mediated By the Interaction Between PD-1 Enriched NK-Cells and CD163+PD-L1+PD-L2+ Tumor Associated Macrophages, That Is More Prominent in Hodgkin Lymphoma Than Diffuse Large B-Cell Lymphoma
Gandhi, Maher K, Arpon, David, Keane, Colm, Han, Erica, Tobin, Josh, Bird, Robert, Hertzberg, Mark S, Self, Marlene, Cross, Donna, Hernandez, Annette, Vari, Frank
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease
Facey, David A., Favaloro, Emmanuel J., Koutts, Jerry, Berndt, Michael C., Hertzberg, Mark S.
Published in British journal of haematology (01.05.1999)
Published in British journal of haematology (01.05.1999)
Get full text
Journal Article
Maintenance Lenalidomide for Adults Aged 18-65 Years with AML in First Complete Remission after Intensive Chemotherapy: A Phase Ib Dose-Escalation Study of the Australasian Leukemia and Lymphoma Group (ALLG)
Wei, Andrew, Lewis, Ian D, Hahn, Uwe, Cull, Gavin, Enjeti, Anoop, Campbell, Philip, He, Simon Z., Hertzberg, Mark S, Seymour, John F
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Final Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Trial: All-Trans Retinoic Acid (ATRA), Intravenous Arsenic Trioxide (ATO) and Idarubicin (IDA) As Initial Therapy for Acute Promyelocytic Leukemia (APL)
Iland, Harry J, Collins, Marnie, Hertzberg, Mark S, Seldon, Michael, Grigg, Andrew P, Firkin, Frank, Supple, Shane G, Campbell, Lynda J, Bradstock, Kenneth F, Seymour, John F
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article